NDC product
NOVOMINSYRUP
NDC 72988-0034 · Lydia Co., Ltd.
Key facts
| Product NDC | 72988-0034 |
|---|---|
| Proprietary name | NOVOMINSYRUP |
| Nonproprietary name | Caffeine Anhydrous, Meclizine Hydrochloride Hydrate, Pyridoxine Hydrochloride |
| Substances | CAFFEINE, MECLIZINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE |
| Dosage form | LIQUID |
| Route | ORAL |
| Labeler | Lydia Co., Ltd. |
| Product type | HUMAN OTC DRUG |
| Marketing category | UNAPPROVED DRUG OTHER |
| Pharmacologic classes | Analogs/Derivatives [Chemical/Ingredient], Antiemetic [EPC], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Emesis Suppression [PE], Methylxanthine [EPC] and 3 more |
| Marketing start | Jan 23, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: